Sharkey, R M <br/><br/>
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  May 1997 
 - 179-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/s002620050371  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, B-Lymphocyte--immunology<br/>Antigens, Neoplasm--immunology<br/>Cell Adhesion Molecules<br/>Humans<br/>Indium Radioisotopes--pharmacokinetics<br/>Lectins<br/>Lymphoma, B-Cell--immunology<br/>Mice<br/>Mice, Nude<br/>Neoplasms, Experimental--immunology<br/>Radioimmunotherapy<br/>Sialic Acid Binding Ig-like Lectin 2<br/>Tumor Cells, Cultured